Dosing Recommendations While human clinical trial data remains limited, current evidence-based recommendations derived from animal studies and clinical experience suggest: General anti-inflammatory dosing: 200-500 mcg administered subcutaneously once daily or 500-1000 mcg twice weekly Acute injury management: Higher doses (500-1000 mcg) may be used daily initially, with tapering to maintenance doses Route of administration: Both systemic (subcutaneous/intramuscular) and local (perilesional) injections have shown similar efficacy
This guide covers what is actually in a MIC injection and what each component does, what the evidence supports and what it doesnt, how lipotropics compare to GLP-1s and every other option on the menu, who is a reasonable candidate, the safety profile, and where these injections legitimately fit inside a supervised medical weight loss program
Third, and perhaps most relevant, it promotes fibroblast migration and collagen synthesis , the exact cellular processes needed to rebuild the damaged annulus fibrosus
Post-discontinuation: Many users reported ongoing benefits after stopping
It's about how we want innovation, compounding, scientific evidence, and patient access to coexist for decades to come